HOW TO CO-MANAGE THYROID
EYE DISEASE (TED)
The American and European Thyroid Associations consensus statement recommends a multidisciplinary approach1
Understanding your role and how to co-manage with your patient’s team of healthcare providers can help provide optimal disease management.
Click to rotate
ENDOCRINOLOGIST
Manages a patient’s thyroid1,2
ENDOCRINOLOGIST
Monitor TSHR antibody, free T3, free T4, T3, & T4
Look for and ask patients about any present or past eye symptoms
Refer patients to a TED Specialist for a comprehensive TED eye exam
Co-manage with eye care provider and TED Specialist
Click to rotate
EYE CARE PROVIDER
Performs eye exams and manages eye disease1,3
EYE CARE PROVIDER
Look for TED symptoms and diagnose early
Conduct baseline assessment, including quality of life evaluation
Calculate Clinical Activity Score (CAS) Refer patients to endocrinologist for thyroid management
Refer to a TED Specialist for treatment options
Co-manage with endocrinologist and TED Specialist
Click to rotate
TED SPECIALIST
Confirms TED diagnosis and prescribes treatment1,3
TED SPECIALIST
Confirms TED diagnosis and evaluates for appropriate treatment
Co-manages with endocrinologist and eye care provider
HEAR FROM A TED SPECIALIST ABOUT THE IMPORTANCE OF CO-MANAGEMENT
Endocrinologist Dr Terry Smith discusses how endocrinologists and eye care providers, such as ophthalmologists, work together to co-manage patients with TED.
Diagnosing and treating TED early can help reduce the risk of potentially permanent eye damage1,4
That is why it is critical to co-manage with a TED Specialist who has the experience to best navigate disease management and treatment for your patients.1
CO-MANAGE WITH A TED
SPECIALIST TO HELP1
Confirm TED diagnosis
Advise and prescribe
treatment
options
Coordinate treatment monitoring
and follow-up care
TSHR, thyroid-stimulating hormone receptor.
Next page > Find a TED Specialist
REFERENCES:
- Burch HB, Perros P, Bednarczuk T, et al. Management of Thyroid Eye Disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Thyroid. 2022;32(12):1-32.
- Phelps PO, Williams K. Thyroid Eye Disease for the primary care physician. Dis Mon. 2014;60(6):292-298.
- Bartalena L, Tanda ML. Graves’ ophthalmopathy. N Engl J Med. 2009;360(10):994-1001.
- Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol. 2015.